Menu
Menu
Cognitive Behavioral Therapy for Insomnia (CBT-I) is now recommended as the first line treatment for chronic insomnia. This recommendation was, interestingly enough, made by the second largest medical organization in the United States (The ACP) and was published in the Annals of Internal Medicine (2016;165(2):125-133).
The recommendation is, in part, based on the following findings.
The Penn Basic CBT-I Course is an intensive review of the principles and practice of this intervention. The 16 hour training, along with the conduct of practicum cases with supervision (peer consultation from credentialed BSM individuals [or established experts]) and targeted readings (Tx manuals and practice papers) should position established clinicians to 1) reliably and effectively deliver CBT-I and 2) be eligible for the credentialing exam that is in development by the SBSM and related agencies. For more information on the credentialing process, keep your eye on this space: http://www.behavioralsleep.org/.
PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This program is worth 16.25 hours CPD for points calculation by your association.
| File type | File name | Number of pages | |
|---|---|---|---|
| CBT-I Manual (18.24 MB) | 274 Pages | Available after Purchase |
Donn Posner, PhD, DBSM, is the founder and president of Sleepwell Consultants and provides consultation to organizations and individuals on a wide variety of sleep health issues including insomnia, circadian dysrhythmia, CPAP adherence, and parasomnias. He is an adjunct clinical associate professor in the department of psychiatry and behavioral sciences at the Stanford University School of Medicine and a consulting psychologist for the Palo Alto VA. Dr. Posner works on a number of grants exploring the effects of CBT-I in Gulf War Veterans, and Veterans with insomnia and Mild Traumatic Brain Injury. He is also conducting a pilot aimed at using CBT-I techniques to decrease fatigue in breast cancer survivors by increasing total sleep time. Dr. Posner spent 25 years as the Director of Behavioral Sleep Medicine for the Sleep Disorders Center of Lifespan Hospitals and was a Clinical Associate Professor in the Department of Psychiatry and Human Behavior at the Warren Alpert School of Medicine at Brown University. He is a member of the American Academy of Sleep Medicine and is one of the first Certified Behavioral Sleep Medicine specialists recognized by that group. He is a founding member of the Society of Behavioral Sleep Medicine, and he has achieved the status of Diplomate of Behavioral Sleep Medicine (DBSM).
Speaker Disclosures:
Financial: Dr. Donn Posner is the founder and president of Sleepwell Consultants and has employment relationships with the Stanford University School of Medicine and the Palo Alto Veterans Institute for Research. He serves as an advisory board member of Brain Train 2020 LTD and iSleep Clinic. He was a previous advisory board member for Dawn Health and Delta Sleep.io. Dr. Posner receives a speaking honorarium and recording royalties from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Dr. Donn Posner is a member of the American Academy of Sleep Medicine, the American Psychological Association, the Society of Behavioral Sleep Medicine, and the Association for Behavioral and Cognitive Therapies.
Michael L. Perlis, PhD is internationally known for his work in the area of Behavioral Sleep Medicine (BSM). He is a coauthor of the first text book in this field and he is the senior author of a published CBT-I treatment manual and a larger text summarizing all BSM treatments. His research includes neurocognitive phenomena in insomnia, the cognitive and/or behavior effects of sedative hypnotics and placebos, the development of alternative treatment approaches for insomnia, and sleep in depression. His work has been, and continues to be, funded by the National Institutes of Health and he has published more than 100 articles and chapters on the sleep research related topics.
In addition to his academic endeavors, he has served on the editorial boards of Sleep, the Journal of Sleep Research, the journal of Sleep Medicine Research and the journal of Behavioral Sleep Medicine. Dr. Perlis has also served as a member, or chair, of several committees and task forces of the Sleep Research Society and the American Academy of Sleep Medicine and he was a founding member of the Society of Behavioral Sleep Medicine and served as the society's first president (2010-2011).
Speaker Disclosures:
Financial: Financial: Michael Perlis has employment relationships with the University of Freiburg and the University of Pennsylvania. He receives royalties as a published author. Michael Perlis receives a consulting fee from Anavex Life Sciences and Nexalin Technology. He receives grants Jazz Pharmaceuticals. Michael Perlis receives a speaking honorarium and recording royalties from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Michael Perlis is a member of the Sleep Research Society, the Association for Behavioral & Cognitive Therapy, and the American Academy of Sleep Medicine. He serves on several editorial boards, for a complete list contact PESI, Inc.
Jason Ellis, PhD, is a Professor of Sleep Science and Director of the Northumbria Sleep Laboratory and Clinic in the United Kingdom. He is a qualified Somnologist – Expert in Behavioural Sleep Medicine from European Sleep Research Society and a Practicing Health Psychologist under the HCPC. He splits his time between his basic research interests: the pathophysiology of sleep disorders (Insomnia, Restless Legs Syndrome, and Circadian Rhythm Disorders), the natural history of Insomnia, and his applied work on Cognitive Behavioral Therapy for Insomnia (CBT-I). Within the latter framework he examines the impact of novel adjunct therapies, the influence of social factors on adherence, and the effective delivery of CBT-I in complex cases and environments. He has worked within the National Health Service in the United Kingdom, delivering CBT-I to individuals with a range of physical and psychological conditions and serves on the editorial boards of Behavioral Sleep Medicine and Sleep Health. He has consulted for various industries and third-sector organizations and provided national guidelines to the British and Scottish governments on the identification and management of sleep problems. He is a serious advocate of public engagement and professional education with regard to behavioral sleep medicine and regularly trains CBT-I to clinicians and primary care physicians in the United Kingdom.
Clinical psychologists, clinical trainees, counselors, PhD/NP level nurses, and physicians interested in the assessment and treatment of insomnia
DAY ONE
DAY TWO
Please wait ...